The aim of the study was to develop and validate a simple and precise reverse-phase High Performance Liquid Chromatography (RP-HPLC) method for quantitative analysis of trans-resveratrol in human and rat plasma. Methods: HPLC method was developed by using Phenomenex Luna C 18 column (150 x 4.6 mm, 5 µm) and the optimized mobile phase comprised of acetonitrile/water in isocratic mode (30:70, v/v) with the flow rate of 1.0 mL/min. Trans-resveratrol was detected at a UV wavelength of 306 nm. Developed method was validated as per International Conference on Harmonization (ICH) M10 guidelines. Results: The proposed method was found simple, precise and linear with regression coefficient of 0.999 which could analyse the samples in nanograms levels with mean percent recovery in the acceptable range of 94.44 -97.44%. The method was precise at the intra-day and inter-day levels as reflected by the relative standard deviation values (less than 3.36%). Trans resveratrol was found to be stable in plasma under different storage conditions. Conclusion: The present investigation demonstrated that the developed method was succesfully applied to accurately determine transresveratrol in human and rat plasma and therefore can be applicable for pre-clinical and clinical studies.
INTRODUCTION
Recently, various food constituents, mainly polyphenols have gained wide attention either as a potential therapeutic or as prophylactic agent in the management of several diseases. 1 Resveratrol (3,5,4'-trihydroxystilbene), a well-known naturally occurring lipophilic polyphenol is first isolated from white hellebore and also present in wide range of other plant products including cranberry, grapevine, blueberry, bilberry and peanut. 2, 3 Resveratrol has two isomers cis and trans from which, the transresveratrol is the therapeutically active form ( Figure 1 ) responsible for health-promoting pharmacological effects like antioxidant, anti-aging, cardioprotective, neuroprotective, anti-inflammatory and anticancer properties. 4 Although trans-resveratrol has shown promising results in several diseases but its unfavorable pharmacokinetic properties such as low bioavailability, extensive metabolism and short half-life limits its use in clinical applications. 5 Currently, trans-resveratrol has been widely incorporated as a nutritional supplement in the day-today life and to consume it as a drug, it is important to develop an appropriate drug delivery systems which can overcome the problems related to its pharmacokinetic. Several HPLC methods are reported in the literature to quantify trans resveratrol in human and rat plasma. 2, [5] [6] [7] [8] [9] However, the reported RP-HPLC methods present several limitations such as long run times, high flow rates, complicated gradient elutions and buffer solutions in mobile phase. The necessity for development of a reliable analytical method for drug assay in biological fluids is a prerequisite for pharmacokinetic studies in animal models and human subjects. With this background, the aim of the study was to develop a simple, rapid and selective RP-HPLC method in accordance with U.S. Food and Drug Administration and ICH guideline 10, 11 to quantify trans-resveratrol in human and rat plasma.
MATERIALS AND METHODS

Materials
Trans-resveratrol (99% pure) and carbamazepine were obtained as free samples from Ms. Sami Labs Ltd., Bangalore, India and Alkem Laboratories Ltd., Mumbai, India, respectively. HPLC-grade acetonitrile (ACN) and methanol were procured from Merck, Mumbai, India. Whole human blood was obtained from K.L.E.S. Dr. Prabhakar Kore Hospital and Medical Research Centre blood bank, (Nehru Nagar, Belagavi-590010, Karnataka, India) and was processed to obtained blank plasma. Deionized water used in the tests was prepared by filtering water through Millipore Direct-Q ® -3 purification system (18.2 MΩ/cm) Millipore (Molsheim, France).
Instrument
The HPLC system (LC-20AD prominence system, Shimadzu, Kyoto, Japan) consisted of an LC-20AD pump, SIL-20 AC HT autosampler, SPD-M20A diode array detector and CBM-20A communication bus module, which was functioned by using computer based Shi-madzu LC solution (version 1.25) software program to analyse the chromatograms. A reverse phase Luna C 18 column (150 x 4.6 mm i.d., 5 µm particle size, Phenomenex, USA) equipped with a guard column (ODS; 4 x 3.0 mm ID, Phenomenex, CA, USA) with a similar particle size was used for separation.
Chromatographic conditions
System was operated with isocratic elution of ACN: Deionized water (30:70 v/v) as mobile phase at a flow rate of 1.0 mL/min under a controlled temperature (30°C) condition. Solvents were prepared by degassing in bath sonicator for 10 min followed by filteration through 0.45 µm membrane Millex HV polyvinylidene fluoride membrane filters (Millipore, Bedford, USA) by using vaccum pump. Drug samples (20 µl ) was injected in HPLC system and detected at 306 nm.
Method validation
Developed method was validated for its selectivity, linearity, system suitability, Limit of Detection (LOD), Limit of Quantitation (LOQ), precision, accuracy and stability.
Human and rat plasma samples preparations
Animal experiments was approved by the Institutional Animal Ethical Committee, KLE College of Pharmacy, Belagavi, India. Human and rat blood samples were centrifuged at 3000 rpm for 10 min at 4°C for plasma separation. 12 The stock solution of the drug was spiked in rat and human plasma to get final concentrations of 2, 4, 6, 8, 10, 12 µg mL -1 (trans-resveratrol). Protein precipitation was performed by treating the spiked plasma samples (150 µL) with acetonitrile (100 µL) followed by centrifugation at 10000 rpm for 10 min at 4°C. Finally, the supernatant was carefully seperated and loaded into the HPLC autosampler for analysis. 13 
Stability experiments
Trans-resveratrol stability was determined in the human and rat plasma at different storage conditions as follows: stability for up to 6 h at 25°C, freezer stability up to 7 days (at -20°C) and freeze-thaw stability (at -20°C). In freeze-thaw stability, cycles were conducted for thrice and the samples were restored to the same condition after withdrawal of aliquots for analysis. The peak areas of the trans-resveratrol obtained at 0 h were used as the reference to determine the relative stability at various storage conditions. All the experiment were performed in triplicates and the samples were considered as stable if the assay values were within the acceptable limit of accuracy (i.e. ± 15% standard deviation). 14 
RESULTS AND DISCUSSION
Method development
Preceding to the validation step, the proposed method was developed in order to provide a simple and optimized procedure, with reduced time and cost of analysis. Therefore, different chromatographic parameters were considered, namely peak number of theoretical plates (N), symmetry (as described by the tailing factor, T), resolution, HETP and retention factor (k′). Initially, the developed RP-HPLC method was optimized by altering the mobile phase composition to obtain symmetrical peak. Varying ratios of solvents mainly consisting of ACN and deionized water with or without methanol was used to optimise the resolution of the peak. Solvent composition consisting of methanol and water in the ratio of 50:50 v/v might yield clear trans-resveratrol peak but had a undesirable impact on the theoretical plate number whereas, solvent composition consisting of ACN and deionized water 50:50 v/v yielded well resolved peak with minor tailing. For the separation of trans-resveratrol, several proportions of ACN and water were tested ranging from 90:10 to 40:60 and analysed to get sharp peak with negligible tailing and shorter retention time. Apart from the mobile phase selection, column temperature is one of the key parameter that demonstrate the significant effect on retention time and peak shape of trans-resveratrol. Experiments with colum temperature in the ranging from 25°C to 45°C revealed that 30°C demonstrated clear peak shape and shorter retention time when compared to others. The developed HPLC system with Luna C 18 column (150 x 4.6 mm i.d., 5µm) was validated by using a solvent mixture of ACN and deionized water (30:70) with isocratic elution at 1.0 mL/min. The injection volume was set up at 20 µL with column temperature of 30°C. Under these chromatographic conditions, trans-resveratrol was detected at wavelength of 306 nm with retention time of 6.1 min ( Figure 2 ).
Method validation
System suitability and selectivity tests
System suitability test is an vital part of the HPLC method development which defines the feasibility and acceptability of the proposed method for the estimation of trans-resveratrol in the plasma. The results of the tested parameters along with their acceptance criteria are summarized in Table 1 . All the parameters such as retention factor (>2), tailing factor (< 2), resolution (>2) and theoretical plate number (>2000) were found to be within the acceptable limits demonstrating desirable resolution, peak symmetry, column efficiency and excellent chromatographic conditions which was used for further validation and sample analysis. Selectivity is described as the ability of a method to separate the analyte from all possibly interfering substance. The selectivity of the method was examined by analyzing blank human and rat plasma detection and spiking with pure compound. Figure 2 shows that there were no interference of plasma in resveratrol elution.
Linearity and range
The linearity of a method is defined as the relationship between the peak area and its corresponding concentrations in the sample solutions. The developed method was found to be linear (Figure 3 ) over the range of 2 - Values are express as mean ± standard deviation (SD); (n=6) 12 µg mL -1 with correlation coefficient; r 2 = 0.999 ( Table  2) indicating acceptable linearity over the proposed concentration range.
LOD and LOQ
The LOD and LOQ were determined by diluting the known concentration of the drug until a signal to noise ratio of nearly 3:1 and 10:1 were obtained ( Table 2 ). The lowest concentration of trans-resveratrol detected in human and rat plasma was 0.030 and 0.032 µg mL -1 respectively. Whereas, the limit of quantitation in the human plasma and rat plasma was found to be 0.090 and 0.099 µg mL -1 respectively.
Precision
The precision of an analytical method indicates the closeness of agreement between the series of measurements obtained from multiple samplings of the identical sample under the similar analytical conditions. Both inter-day (at three consecutive days) and intra-day (repeatability) assays were performed at three different concentrations (in triplicates) and results are shown in Table 3 . The percent relative standard deviation (%RSD) of the total peak areas were <3.36% which indicates that the developed method is precise.
Accuracy
The accuracy of the bioanalytical method is defined as the percent difference between the mean experimental value and true value. Accuracy was evaluated by conducting a recovery experiment in pre-analysed biological fluid (human and rat plasma). The assay was performed by following standard addition method at three different concentrations (50%, 100% and 150%) of preanalysed trans-resveratrol samples in triplicates. The mean percent recovery of trans resveratrol from biological fluid were in the range of 94.44 to 97.44 % with < 1 % RSD. The results summarized in the Table 4 . clearly indicate that the developed method displayed low variability and a strong agreement between experimental and true values.
Trans-resveratrol stability
Trans-resveratrol was stable for 6h at 23°C -25°C and 7 days at freezing condition (-20°C). Trans resveratrol was also stable for 3 freeze-thaw (F/T) cycles ( Table 5) .
Comparison with previous published methods Comparative analysis of methods described in the existing literature and the current study reveals the advantage of the developed method ( Table 6 ). The developed method uses conventional solvents like water and ACN and has the flowrate of 1mL min -1 with retention time of 6 min which suggests that it is economic, cheap and fast when compared to other methods. Use of simple mobile phase without strong buffers/expensive HPLC grade solvents and a conventional C 18 column makes the method versatile for the analysis of trans-resveratrol.
Comparison with previous published methods
Comparative analysis of methods described in the existing literature and the current study reveals the advantage of the developed method ( Table 6 ). The developed method uses conventional solvents like water and ACN and has the flowrate of 1mL min -1 with retention time of 6 min which suggests that it is economic, cheap and fast when compared to other methods. Use of simple mobile phase without strong buffers/expensive HPLC grade solvents and a conventional C 18 column makes the method versatile for the analysis of trans-resveratrol.
CONCLUSION
A simple, sensitive and rapid RP-HPLC method was successfully developed according to the ICH guideline for the estimation of trans-resveratrol in human and rat plasma. The simple chromatographic conditions and pre-treatment procedure is easy and fast to perform. The acceptable limit of selectivity, precision, accuracy and appropriate retention time only 6 min make it suitable for preclinical and clinical studies. 
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